Cite
Inflammatory Bowel Disease and Guillain Barre Syndrome in FCHO1 Deficiency
MLA
Ömer Faruk Beşer, et al. “Inflammatory Bowel Disease and Guillain Barre Syndrome in FCHO1 Deficiency.” Journal of Clinical Immunology, vol. 41, May 2021, pp. 1406–10. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....567d8f10960dce77ea7682b64e613444&authtype=sso&custid=ns315887.
APA
Ömer Faruk Beşer, Ayca Kiykim, Ali Islek, Serdar Nepesov, Gokhan Baysoy, Elif Karakoc-Aydiner, Sezin Aydemir, Yöntem Yaman, Haluk Cokugras, Bernice Lo, Yasemin Kendir Demirkol, Safa Baris, Satanay Hubrack, Fügen Çullu Çokuğraş, & Ahmet Ozen. (2021). Inflammatory Bowel Disease and Guillain Barre Syndrome in FCHO1 Deficiency. Journal of Clinical Immunology, 41, 1406–1410.
Chicago
Ömer Faruk Beşer, Ayca Kiykim, Ali Islek, Serdar Nepesov, Gokhan Baysoy, Elif Karakoc-Aydiner, Sezin Aydemir, et al. 2021. “Inflammatory Bowel Disease and Guillain Barre Syndrome in FCHO1 Deficiency.” Journal of Clinical Immunology 41 (May): 1406–10. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....567d8f10960dce77ea7682b64e613444&authtype=sso&custid=ns315887.